John Crown (Independent) | Oireachtas source

The problem with the National Centre for Pharmacoeconomics is that I believe it does not take the most nuanced view of the totality of the health care costs associated with a new product when working out how much it costs and I am sick of it. The case one needs to make is that it can decrease resource utilisation, but this case may need to be made to a body other than the National Centre for Pharmacoeconomics.